Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The signaling pathways and targets of traditional Chinese medicine and natural medicine in triple-negative breast cancer
Zimei Yang, Qiuhua Zhang, Linghong Yu, et al.
Journal of Ethnopharmacology (2020) Vol. 264, pp. 113249-113249
Closed Access | Times Cited: 163

Showing 1-25 of 163 citing articles:

Natural products targeting the MAPK-signaling pathway in cancer: overview
Aiwen Shi, Li Liu, Shuang Li, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 1
Open Access | Times Cited: 15
Network pharmacology combined with experimental verification to explore the potential mechanism of naringenin in the treatment of cervical cancer
Ji Zhou, Haoying Li, Ben Wu, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 15
β‐Elemene Inhibits Adrenocortical Carcinoma Cell Proliferation and Migration, and Induces Apoptosis by Up‐Regulating miR‐486‐3p/Targeting NPTX1 Axis
Yan Lin, Tailin Guo, Lishuang Che, et al.
Molecular Carcinogenesis (2025)
Open Access | Times Cited: 1
Pharmacological Potential of Betulin as a Multitarget Compound
Feyisayo O. Adepoju, Kingsley C. Duru, Erguang Li, et al.
Biomolecules (2023) Vol. 13, Iss. 7, pp. 1105-1105
Open Access | Times Cited: 34
The signaling pathways of selected traditional Chinese medicine prescriptions and their metabolites in the treatment of diabetic cardiomyopathy: a review
Wencan Li, Xiang Liu, Zheng Liu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 11
Comprehensive network pharmacology and experimental study to investigate the effect and mechanism of solasonine on breast carcinoma treatment
Wenkai Ge, Min Gao, Yingqi Dai, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
Uncovering the mechanisms of dandelion against triple-negative breast cancer using a combined network pharmacology, molecular pharmacology and metabolomics approach
Jiameng Qu, Fan Ke, Ziru Liu, et al.
Phytomedicine (2022) Vol. 99, pp. 153986-153986
Closed Access | Times Cited: 34
Anticancer Effect of Tanshinones on Female Breast Cancer and Gynecological Cancer
Jin Zhou, YU Cheng-hao, Cheng Peng
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 32
Arctium lappa (Burdock): Insights from ethnopharmacology potential, chemical constituents, clinical studies, pharmacological utility and nanomedicine
Nermeen Yosri, Sultan M. Alsharif, Jianbo Xiao, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 158, pp. 114104-114104
Open Access | Times Cited: 31
Active Ingredients from Chinese Medicine for Combination Cancer Therapy
Xuan Wang, Jing Li, Ruie Chen, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 11, pp. 3499-3525
Open Access | Times Cited: 16
Rapid identification of chemical constituents and dynamic metabolic profile of Shenqi-Tiaoshen formula in rat plasma based on UPLC-Q-TOF/MSE
Xuewen Rong, Huan Wu, Ruotong Huang, et al.
Journal of Pharmaceutical and Biomedical Analysis (2024) Vol. 241, pp. 115981-115981
Closed Access | Times Cited: 6
Jaceosidin induces apoptosis and inhibits migration in AGS gastric cancer cells by regulating ROS-mediated signaling pathways
Jian Liu, Shumei Li, Tang Yan-jun, et al.
Redox Report (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 6
A Review of Traditional Chinese Medicine for Triple Negative Breast Cancer and the Pharmacological Mechanisms
Qinhang Wu, Hongkai Yan, Ziyi Kang
The American Journal of Chinese Medicine (2024) Vol. 52, Iss. 04, pp. 987-1011
Closed Access | Times Cited: 6
Peiminine triggers ferroptosis to inhibit breast cancer growth through triggering Nrf2 signaling
Nian Yi, Li Wang, Zhongjun Jiang, et al.
Tissue and Cell (2024) Vol. 87, pp. 102323-102323
Closed Access | Times Cited: 5
The Application of Traditional Chinese Medicine-Derived Formulations in Cancer Immunotherapy: A Review
Yanyun Li, Changying Li, Jia Fan, et al.
Cancer Management and Research (2025) Vol. Volume 17, pp. 23-34
Open Access
Mechanistic exploration of Traditional Chinese Medicine regulation on tumor immune microenvironment in the treatment of triple-negative breast cancer: based on CiteSpace and bioinformatics analysis
Dandan Feng, Dongqing Pu, Juan Ren, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Mesua ferrea L. extract inhibits cell invasion and tumor growth in breast cancer in vitro and in vivo
Zhiying Liu, Ge Ge, Shuangshuang Ma, et al.
Tissue and Cell (2025) Vol. 93, pp. 102750-102750
Closed Access
Apoptosis Induction and S-Phase Cell Cycle Blockade in Human Lung Adenocarcinoma Cell Line (A549) by Chlorophytum comosum (Thunb.) Jaques
Shehla Adhami, Humaira Farooqi, Asrar Ahmad Malik
Research Square (Research Square) (2025)
Closed Access
Anti-TNBC effects of Lappaol F by targeting epithelial-mesenchymal transition via regulation of GSK-3β/YAP/β-catenin and PI3K/AKT pathways
Qiqi Meng, Zhiping Li, Xiaofeng He, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Identifying traditional Chinese medicine combinations for breast cancer treatment based on transcriptional regulation and chemical structure
Shensuo Li, Lijun Zhang, Chengkuan Liu, et al.
Chinese Medicine (2025) Vol. 20, Iss. 1
Open Access
Sarsasapogenin Inhibits HCT116 and Caco‐2 Cell Malignancy and Tumor Growth in a Xenograft Mouse Model of Colorectal Cancer by Inactivating MAPK Signaling
Ping Pan, Zhen Zhang, Yang Xu, et al.
Journal of Biochemical and Molecular Toxicology (2025) Vol. 39, Iss. 3
Closed Access
Exploring the mechanism of baicalein on breast cancer based on network pharmacology, molecular docking and in vivo experiments
Gaotao Zhang, Zhiqin Liu, Yuanzhuang Xu, et al.
Toxicology and Applied Pharmacology (2025), pp. 117297-117297
Closed Access
NPCDR: natural product-based drug combination and its disease-specific molecular regulation
Xueni Sun, Yintao Zhang, Ying Zhou, et al.
Nucleic Acids Research (2021) Vol. 50, Iss. D1, pp. D1324-D1333
Open Access | Times Cited: 35
Signaling Pathways and Natural Compounds in Triple-Negative Breast Cancer Cell Line
Citra Dewi, Adryan Fristiohady, Riezki Amalia, et al.
Molecules (2022) Vol. 27, Iss. 12, pp. 3661-3661
Open Access | Times Cited: 23
Co-delivery of doxorubicin and hydroxychloroquine via chitosan/alginate nanoparticles for blocking autophagy and enhancing chemotherapy in breast cancer therapy
Hui Zhang, Qingwen Xue, Zihan Zhou, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top